Physician profile

William H Ryan, III

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Plano, TX

NPI 1790773240

$2,497.76

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$201.42

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Allergan, INC. $1,268.65 2019
Medtronic, INC. $829.68 2022-2023 Mosaic, Contour 3d
Artivion, INC. $150.83 2023 Cardiac Non-Synergraft
Atricure, INC. $150.57 2019
Edwards Lifesciences Corporation $98.03 2019-2021

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

William H Ryan, III

$2,497.76

in general payments reported 2019-2025

Years
2019-2023
Top company
Allergan, INC.

https://glasscript.com/doctor/353291/william-h-ryan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.